Actively Recruiting
Radiofrequency vs. Ultrasound Therapy for Shoulder Joint in Stroke Patients: A Comparative Clinical Trial
Led by Cairo University · Updated on 2025-10-02
45
Participants Needed
1
Research Sites
6 weeks
Total Duration
On this page
Sponsors
C
Cairo University
Lead Sponsor
D
Delta University for Science and Technology
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of the current study is to: Compare between radiofrequency (TECAR) therapy and ultrasound on Shoulder Pain, Range of Motion and Functional Outcome in Patients with stroke.
CONDITIONS
Official Title
Radiofrequency vs. Ultrasound Therapy for Shoulder Joint in Stroke Patients: A Comparative Clinical Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Fourty-five hemiplegic patients with shoulder pain post- stroke from both sexes will participate in this study.
- The patients will be older than 18 years old (30-60 years old)
- The presence of sub-acute shoulder pain (more than 3 months).
- Sub-acute stroke survivors (3 months post-stroke).
- score of 1|1+ points on the Modified Ashworth Scale (MAS) on shoulder joint.
- Stage 2 or above according to Brunnstrom function assessment of shoulder joint
- All conducted patients experienced a single stroke during the last 3 months with cognitive capacity that will enable them to comprehend and follow the instructions (Mini-Mental Scale score > 24).
You will not qualify if you...
-
The following patients will be excluded from the study patients with:
- Bilateral adhesive capsulitis
- Systemic diseases such as rheumatoid arthritis, malignancies, heart diseases, infections, coagulation disorders, full rotator cuff tears
- A history of recent shoulder surgery, neurological problems involving the upper extremity, shoulder joint osteoarthritis
- Upper extremity fractures, cervical radiculopathy
- Impaired sensation, having a heart pacemaker, pregnancy
- Injuries in the upper limbs
- Other neurological diseases or cancer
- Osteosynthesis material or pacemaker
- Botulinum toxin or antispastic treatment 3 months prior to studying.
- Any contraindication to massage and Tecar as skin infections, inflammatory vascular diseases, or acute inflammation.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Physical Therapy Delta University
Gamasa, Egypt
Actively Recruiting
Research Team
R
Rewan M Aloush
CONTACT
M
Muhammed E Abulftouh
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here